-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Xcelerate, Inc. Announces Uplisting to OTCQB Market
Xcelerate, Inc. Announces Uplisting to OTCQB Market
MAULDIN, SC / ACCESSWIRE / August 1, 2022 / Xcelerate, Inc. (OTCQB:XCRT), today announces that the OTC Market Group has approved the Company's application for uplisting to the OTCQB® Venture Market (the "OTCQB"). The Company will commence trading on the OTCQB with the market open on August 1, 2022, under the symbol "XCRT"
"Trading on OTCQB is an important achievement for our Company. We believe it will provide increased transparency and improved liquidity to both existing and prospective shareholders," said Michael O'Shea, Chief Executive Officer of Xcelerate, Inc. "Our plans include continuing with our corporate growth through the balance of this year and beyond. We believe listing on the OTCQB will allow our story to reach a wider investor audience, a key objective for the Company in 2022. I would like to thank our partners and investors for their continued support as we continue to execute on our business plan."
OTCQB is operated by OTC Markets Group, Inc. and is designed for early-stage and developing companies in the United States and abroad. To be eligible for OTCQB quotes, companies must be current in their disclosure filings, have audited financial statements, and undergo an annual validation and management certification process. Companies must also meet minimum bid testing and other financial terms. OTCQB is recognized as an established public market by the Securities and Exchange Commission ("SEC") and provides current public information to investors in need of securities analysis, valuation, and trading.
ABOUT XCELERATE INC.
In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology. Visit to learn more.
SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.
Xcelerate Contact:
Info@Xcelerate.Global
SOURCE: Xcelerate, Inc.
View source version on accesswire.com:
MAULDIN, SC / ACCESSWIRE / August 1, 2022 / Xcelerate, Inc. (OTCQB:XCRT), today announces that the OTC Market Group has approved the Company's application for uplisting to the OTCQB® Venture Market (the "OTCQB"). The Company will commence trading on the OTCQB with the market open on August 1, 2022, under the symbol "XCRT"
南卡罗来纳州莫尔丁,ACCESSWIRE/2022年8月1日/XCelerate,Inc.(场外交易市场代码:XCRT)今天宣布,场外市场小组已批准该公司进入场外®创业板市场的申请(“场外交易市场QB”)。该公司将于2022年8月1日在OTCQB开始交易,交易代码为“XCRT”
"Trading on OTCQB is an important achievement for our Company. We believe it will provide increased transparency and improved liquidity to both existing and prospective shareholders," said Michael O'Shea, Chief Executive Officer of Xcelerate, Inc. "Our plans include continuing with our corporate growth through the balance of this year and beyond. We believe listing on the OTCQB will allow our story to reach a wider investor audience, a key objective for the Company in 2022. I would like to thank our partners and investors for their continued support as we continue to execute on our business plan."
Xcelerate公司的首席执行官Michael O‘Shea说:“OTCQB的交易是我们公司的一项重要成就。我们相信,它将为现有股东和潜在股东提供更高的透明度和更好的流动性。”我们的计划包括在今年和以后的剩余时间里继续我们的公司增长。我们相信在OTCQB上市将使我们的故事接触到更广泛的投资者受众,这是公司2022年的关键目标。我要感谢我们的合作伙伴和投资者在我们继续执行我们的商业计划时给予的持续支持。
OTCQB is operated by OTC Markets Group, Inc. and is designed for early-stage and developing companies in the United States and abroad. To be eligible for OTCQB quotes, companies must be current in their disclosure filings, have audited financial statements, and undergo an annual validation and management certification process. Companies must also meet minimum bid testing and other financial terms. OTCQB is recognized as an established public market by the Securities and Exchange Commission ("SEC") and provides current public information to investors in need of securities analysis, valuation, and trading.
OTCQB由OTC Markets Group,Inc.运营,专为美国和海外处于早期阶段和发展中的公司而设计。要有资格获得OTCQB报价,公司必须在其披露文件中保持最新,已审计财务报表,并经历年度验证和管理认证过程。公司还必须满足最低投标测试和其他财务条款。场外交易市场被美国证券交易委员会(“美国证券交易委员会”)认可为成熟的公开市场,为需要进行证券分析、估值和交易的投资者提供最新的公开信息。
ABOUT XCELERATE INC.
关于Xcelerate公司
In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology. Visit to learn more.
2020年5月,Xcelerate开始实施一项新的业务计划,该计划包括医疗行业内两项独立但相关的业务,包括(I)拥有和许可各种形式的医疗设备以及专利、正在申请的专利和技术许可证组合,以及(Ii)开发虚拟医疗技术,通过使用该技术扩大医生的覆盖范围,帮助发展中国家的患者获得医疗服务。访问以了解更多信息。
SAFE HARBOR
安全港
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.
本新闻稿可能包含经修订的1934年证券交易法(“交易法”)第21E节所指的前瞻性信息,包括与公司、其董事或高级管理人员在以下方面的意图、信念或当前预期有关的所有不是历史事实的陈述:(1)公司的融资计划;(2)影响公司财务状况或经营结果的趋势;(3)公司的增长战略和经营战略;以及(4)宣布和支付股息。“可能”、“将”、“将”、“预期”、“估计”、“预期”、“相信”、“打算”以及类似的表述及其变体旨在识别前瞻性陈述。请投资者注意,任何此类前瞻性陈述都不是对未来业绩的保证,涉及风险和不确定性,其中许多风险和不确定性超出了公司的控制能力,实际结果可能与前瞻性陈述中预测的结果大不相同 由以下原因导致 各种因素。
Xcelerate Contact:
Info@Xcelerate.Global
Xcelerate联系人:
邮箱:Info@Xcelerate.Global
SOURCE: Xcelerate, Inc.
资料来源:Xcelerate公司
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧